Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Cosmos Health (COSM) Loans and Notes Receivables (2023 - 2025)

Cosmos Health's Loans and Notes Receivables history spans 3 years, with the latest figure at $487638.0 for Q4 2025.

  • Quarterly results put Loans and Notes Receivables at $487638.0 for Q4 2025, down 20.64% from a year ago — trailing twelve months through Dec 2025 was $487638.0 (down 20.64% YoY), and the annual figure for FY2025 was $487638.0, down 20.64%.
  • Loans and Notes Receivables for Q4 2025 was $487638.0 at Cosmos Health, down from $714935.0 in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $714935.0 in Q3 2025 to a low of $407318.0 in Q1 2024.
  • The 3-year median for Loans and Notes Receivables is $491897.0 (2024), against an average of $538739.4.
  • Peak annual rise in Loans and Notes Receivables hit 63.56% in 2025, while the deepest fall reached 20.64% in 2025.
  • Year by year, Loans and Notes Receivables stood at $411858.0 in 2023, then surged by 49.2% to $614473.0 in 2024, then fell by 20.64% to $487638.0 in 2025.
  • According to Business Quant data, Loans and Notes Receivables over the past three periods came in at $487638.0, $714935.0, and $615592.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.